This week the UCLH Cancer Collaborative launched the first pilot project of an NHS ovarian cancer surveillance service for women who carry a faulty BRCAS gene and have chosen not to have their ovaries and fallopian tubes removed.

This is the first time that this technology has been piloted as an NHS service and heralds a significant step towards meeting recommendation in the National Cancer Strategy to improve early diagnosis.

The initiative has been heavily supported by CEW UK, a not-for-profit professional organisation with more than 1,000 members in the United Kingdom, from the beauty industry and related fields, including Spabreaks.com’s Managing Director, Abi Wright. They are a force for leading the conversation and pushing the boundaries in the beauty industry to move it forward.

CEW UK has been a big supporter of The Eve Appeal, the research funding organisation for this initiative, for the last 10 years, and has donated £25,000 each year to the appeal, raised through income and events throughout the year.

CEW UK also recently supported the launch of The Eve Appeal’s new Get Lippy initiative, which is about getting women to talk more openly about vaginal health, changes to their bodies and signs to look out for.

Caroline Neville MBE, President of CEW UK said of the pilot NHS scheme: “Every person who has turned out and supported our events has helped to make this happen, and it is hoped it will go on to deliver something very precious for all UK women, for CEW and the whole beauty industry.

Athena Lamnisos, Chief Executive of The Eve Appeal cancer charity said: “This programme offers women some peace of mind and the ability to make difficult decisions about surgery in the time that suits them, their lives and their health”